Understanding how mineralocorticoid receptors regulate gene activity
Multifaceted Regulation of Mineralocorticoid Receptor Transcriptional Activities
['FUNDING_OTHER'] · EMORY UNIVERSITY · NIH-10941132
This study is looking at how certain receptors in your body help control important functions like fluid balance and inflammation, which could lead to new treatments for heart and kidney problems.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | EMORY UNIVERSITY (nih funded) |
| Locations | 1 site (ATLANTA, UNITED STATES) |
| Trial ID | NIH-10941132 on ClinicalTrials.gov |
What this research studies
This research investigates the molecular mechanisms by which mineralocorticoid receptors (MR) control gene expression in various tissues, including the heart, brain, and adipose tissue. By focusing on the interactions between different domains of the receptor, the study aims to uncover how these receptors contribute to important biological processes such as fluid balance and inflammation. The research employs advanced techniques to analyze the structure and function of these receptors, which could lead to new therapeutic strategies for conditions like cardiovascular and renal diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from cardiovascular or renal diseases, particularly those with conditions related to fluid and electrolyte imbalances.
Not a fit: Patients with conditions unrelated to mineralocorticoid receptor activity or those not experiencing cardiovascular or renal issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for cardiovascular and renal diseases by enhancing our understanding of mineralocorticoid receptor function.
How similar studies have performed: Previous research has shown promise in targeting mineralocorticoid receptors for therapeutic purposes, indicating that this approach has potential for success.
Where this research is happening
ATLANTA, UNITED STATES
- EMORY UNIVERSITY — ATLANTA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: LIU, XU — EMORY UNIVERSITY
- Study coordinator: LIU, XU
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.